Exhibit
10.21


ESCROW
AGREEMENT (PUBLIC OFFERING)


 


Page
1


 


AGREEMENT
made this 19th day of June, 2015 by and among DelMar Pharmaceuticals, Inc. (the "Issuer") and the Placement Agent
whose names and addresses appear on the Information Sheet (as defined herein) attached to this Agreement and Continental Stock
Transfer & Trust Company, 17 Battery Place, 8th Floor, New York, New York 10004. (The “Escrow Agent”).


 


W
I T N E S S E T H:


 


WHEREAS,
the Issuer has filed with the Securities and Exchange Commission (the "Commission") a Registration Statement (the "Registration
Statement") covering a proposed public offering of its securities as described on the Information Sheet;


 


WHEREAS,
the Placement Agent proposes to offer the Securities, as agent for the Issuer, for sale to the public on a "best efforts,
all or none" basis with respect to the Minimum Securities Amount and Minimum Dollar Amount and at the price per share or
other unit all as set forth, on the Information Sheet;


 


WHEREAS
the Issuer and the Placement Agent propose to establish an Escrow Account (the "Escrow Account"), to which subscription
monies which are received by the Escrow Agent from the Placement Agent in connection with such public offering are to be credited,
and the Escrow Agent is willing to establish the Escrow Account and the terms are subject to the conditions hereinafter set forth;
and


 


WHEREAS,
the Escrow Agent has an agreement with JP Morgan Chase to establish a special Bank Account (the "Bank Account") into
which the subscription monies, which are received by the Escrow Agent from investors (or any sub-agent on behalf of such investors)
and credited to the Escrow Account, are to be deposited;


 


NOW,
THEREFORE in consideration of the premises and mutual covenants herein contained, the parties hereto hereby agree as follows:


 


1.
Information Sheet. Each capitalized term not otherwise defined in this Agreement shall have the meaning set
forth for such term on the information sheet which is attached to this Agreement and is incorporated by reference herein and made
a pact hereof (the "Information Sheet").


 


2.
Establishment of the Bank Account.


 


2.1
The Escrow Agent shall establish a non-interest bank account at the branch of JP Morgan Chase selected by the Escrow Agent, and
bearing the designation set forth on the Information Sheet (heretofore defined as the "Bank Account"). The purpose of
the Bank Account is for (a) the deposit of all subscription monies (wire transfers only) which are received from prospective purchasers
of the Securities and are delivered to the Escrow Agent, (b) the holding of amounts of subscription monies which are collected
through the banking system, and (c) the disbursement of collected funds, all as described herein.


 


2.2
On or before the date of the initial deposit in the Bank Account pursuant to this Agreement, the Placement Agent shall notify
the Escrow Agent in writing of the Effective Date of the Registration Statement (the "Effective Date"), and the Escrow
Agent shall not be required to accept any amounts for credit to the Escrow Account or for deposit in the Bank Account prior to
its receipt of such notification.


 


2.3
The Offering Period, which shall be deemed to commence on the Effective Date, shall consist of the number of calendar days or
business days set forth on the Information Sheet. The Offering Period shall be extended by an Extension Period only if the Escrow
Agent shall have received written notice thereof at least five (5) business days prior to the expiration of the offering Period.
The Extension Period, which shall be deemed to commence on the next calendar day following the expiration of the offering Period,
shall consist of the number of calendar days or business days set forth on the Information Sheet. The last day of the Offering
Period, or the last day of the Extension Period (if the Escrow Agent has received written notice thereof as hereinabove provided),
is referred to herein as the "Termination Date”. Except as provided in Section 4.3 hereof, after the Termination Date
neither the investors nor any sub-agent on their behalf shall deposit, and the Escrow Agent shall not accept, any additional amounts
representing payments by prospective purchasers.


 






    	 



    	 



    

  


Page
2.


 


3.
Deposits to the Bank Account.


 


3.1
Following effectiveness, investors shall promptly deliver to the Escrow Agent all monies in respect of the purchase of Securities,
which monies shall be solely in the form of wire transfers. Upon the Escrow Agent’s receipt of such monies, they shall be
credited to the Escrow Account.


 


3.2
Promptly after receiving subscription monies as described in Section 3.1, the Escrow Agent shall deposit the same into the
Bank Account. Amounts of monies so deposited are hereinafter referred to as “Escrow Amounts”. The Escrow Agent
shall cause the Bank to process all Escrow Amounts for collection through the banking system. Simultaneously with each deposit
to the Escrow Account, the Placement Agent (or other placement agents or sub-agents involved in the proposed public offering,
as the case may be) shall inform the Escrow Agent in writing of the name, address, and the tax identification number of the purchaser,
the amount of Securities subscribed for by such purchase, and the aggregate dollar amount of such subscription (collectively,
the “Subscription Information”).


 


3.3
Wire transfers representing payments by prospective purchasers shall not be deemed deposited in the Escrow Account until the
Escrow Agent has received in writing the Subscription Information required with respect to such payments.


 


 


3.4
The Escrow Agent shall not be required to accept in the Escrow Account any amounts representing payments by prospective purchasers
except during the Escrow Agent's regular business hours.


 


3.5
Only those Escrow Amounts, which have been deposited in the Bank Account and which have cleared the banking system and have been
collected by the Escrow Agent, are herein referred to as the "Fund".


 


3.6
If the proposed offering is terminated before the Termination Date, the Escrow Agent shall refund any portion of the Fund prior
to disbursement of the Fund in accordance with Article 4 hereof upon instructions in writing signed by both the Issuer and the
Placement Agent.


 


4.
Disbursement from the Bank Account.


 


4.1
Subject to Section 4.3 below, if by the close of regular banking hours on the Termination Date the Escrow Agent determines
that the amount in the Fund is less than the Minimum Dollar Amount or the Minimum Securities Amount, as indicated
by the Subscription information submitted to the Escrow Agent, then in either such case, the Escrow Agent shall promptly refund
to each prospective purchaser the amount of payment received from such purchaser which is then held in the Fund or which thereafter
clears the banking system, without interest thereon or deduction therefrom, by drawing checks on the Bank Account for the amounts
of such payments and transmitting them to the purchasers. In such event, the Escrow Agent shall promptly notify the Issuer and
the Placement Agent of its distribution of the Fund.


 


4.2
Subject to Section 4.3 below, if at any time up to the close of regular banking hours on the Termination Date, the Escrow Agent
determines that the amount in the Fund is at least equal to the Minimum Dollar Amount and represents the sale of not less than
the Minimum Securities Amount, the Escrow Agent shall promptly notify the Issuer and the Placement Agent of such fact in writing.
The Escrow Agent shall promptly disburse the Fund, by drawing checks on the Bank Account in accordance with instructions in writing
signed by both the Issuer and the Placement Agent as to the disbursement of the Fund, promptly after it receives such instructions.


 


4.3
Upon disbursement of the Fund pursuant to the terms of this Article 4, the Escrow Agent shall be relieved of all further
obligations and released from all liability under this Agreement. It is expressly agreed and understood that in no event
shall the aggregate amount of payments made by the Escrow Agent exceed the amount of the Fund.


 


 




    	 



    	 



    

 


Page
3.


 


 


5.
Rights, Duties and Responsibilities of Escrow Agent. It is understood and agreed that the duties of the Escrow Agent are
purely ministerial in nature, and that:


 


5.1
The Escrow Agent shall provide the Issuer and/or the Placement Agent with online “view only” access to the bank subscription
account, to view the Escrow Amounts which have been deposited in the Bank Account and of the amounts, constituting the Fund, which
have cleared the banking system and have been collected by the Escrow Agent.


 


5.2
The Escrow Agent shall not be responsible for or be required to enforce any of the terms or conditions of the placement agent
agreement or any other agreement between the Placement Agent and the Issuer nor shall the Escrow Agent be responsible for the
performance by the Placement Agent or the Issuer of their respective obligations under this Agreement.


 


5.3
The Escrow Agent shall not be required to accept any Subscription Information pertaining to prospective purchasers unless such
Subscription Information is accompanied by wire transfers meeting the requirements of Section 3.1, nor shall the Escrow Agent
be required to keep records of any information with respect to payments deposited except as to the amount of such payments; however,
the Escrow Agent shall notify the Placement Agent within a reasonable time of any discrepancy between the amount set forth in
any Subscription Information and the amount delivered to the Escrow Agent therewith. Such amount need not be accepted for deposit
in the Escrow Account until such discrepancy has been resolved.


 


5.4
The Escrow Agent shall be entitled to rely upon the accuracy, act in reliance upon the contents, and assume the
genuineness of any notice, instruction, certificate, signature, instrument or other document which is given to the Escrow
Agent pursuant to this Agreement without the necessity of the Escrow Agent verifying the truth or accuracy thereof. The Escrow
Agent shall not be obligated to make any inquiry as to the authority, capacity, existence or identity or any person purporting
to give any such notice or instructions or to execute any such certificate, instrument or other document.


 


5.6
If the Escrow Agent is uncertain as to its duties or rights hereunder or shall receive instructions with respect to the Bank Account,
the Escrow Amounts or the Fund which, in its sole determination, are in conflict either with other, instructions received by it
or with any provision of this Agreement, it shall be entitled to hold the Escrow Amounts, the Fund, or a portion thereof, in the
Bank Account pending the resolution of such uncertainty to the Escrow Agent's sole satisfaction, by final judgment of a court
or courts of competent jurisdiction or otherwise; or the Escrow Agent, at its sole option, may deposit the Fund (and any other
Escrow Amounts that thereafter become part of the Fund) with the Clerk of a court of competent jurisdiction in a proceeding to
which all parties in interest are joined. Upon the deposit by the Escrow


 


Agent
of the Fund with the Clerk of any court, the Escrow Agent shall be relieved of all further obligations and released from all liability
hereunder.


 


5.7
The Escrow Agent shall not be liable for any action taken or omitted hereunder, or for the misconduct of any employee, agent or
attorney appointed by it, except in the case of willful misconduct or gross negligence. The Escrow Agent shall be entitled to
consult with counsel of its own choosing and shall not be liable for any action taken, suffered or omitted by it in accordance
with the advice of such counsel.


 


5.8
The Escrow Agent shall have no responsibility at any time to ascertain whether or not any security interest exists in the Escrow
Amounts, the Fund or any part thereof or to file any statement under the Uniform Commercial Code with respect to the Fund or any
part thereof.


 


6.
Amendment; Resignation. This Agreement may be altered or amended only with the written consent of the Issuer, the Placement
Agent and the Escrow Agent. The Escrow Agent may resign for any reason upon three (3) business days' written notice to the Issuer
and the Placement Agent. Should the Escrow Agent resign as herein provided, it shall not be required to accept any deposit,
make any disbursement or otherwise dispose of the Escrow Amounts or the Fund, but its only duty shall be to hold the Escrow
Amounts until they clear the banking system and the Fund for a period of not more than five (5) business days following the effective
date of such resignation, at which time (a) if a successor escrow agent shall have been appointed and written notice thereof (including
the name and address of such successor escrow agent) shall have been given to the resigning Escrow Agent by the Issuer, the Placement
Agent and such successor escrow agent, then the resigning Escrow Agent shall pay over to the successor escrow agent the Fund,
less any portion thereof


 






    	 



    	 



    

 


Page
4


 


 


previously
paid out in accordance with this Agreement; or (b) if the resigning Escrow Agent shall not have received written notice signed
by the Issuer, the Placement Agent and a successor escrow agent, then the resigning Escrow Agent shall promptly refund the amount
in the Fund to each prospective purchaser without interest thereon or deduction therefrom, and the resigning Escrow Agent shall
promptly notify the Issuer and the Placement Agent in writing of its liquidation and distribution of the Fund; whereupon, in either
case, the Escrow Agent shall be relieved of all further obligations and released from all liability under this Agreement. Without
limiting the provisions of Section 8 hereof, the resigning Escrow Agent shall be entitled to be reimbursed by the Issuer for any
expenses incurred in connection with its resignation, transfer of the Fund to a successor escrow agent or distribution of the
Fund pursuant to this Section 6.


 


7.
Representations and Warranties. The issuer and the Placement Agent hereby jointly and severally represent and warrant to
the Escrow Agent that:


 


7.1
No party other than the parties hereto and the prospective purchasers have, or shall have, any lien, claim or security interest
in the Escrow Amounts or the Fund or any part thereof.


 


7.2
No financing statement under the Uniform Commercial Code is on file in any jurisdiction claiming a security interest in or describing
(whether specifically or Generally) the Escrow Amounts or the Fund or any part thereof.


 


7.3
The Subscription information submitted with each deposit shall, at the time of submission and at the time of disbursement of the
Fund, be deemed a representation and warranty that such deposit represents a bona fide payment by the purchaser described therein
for the amount of securities in such described as Subscription Information.


 


7.4
All of the information contained in the Information Sheet is, as of the date hereof, and will be, at the time of any disbursement
of the Fund, true and correct.


 


7.5
Reasonable controls have been established and required due diligence performed to comply with “Know Your Customer”
regulations, USA Patriot Act, Office of the Foreign Asset Control (OFAC) regulations and the Bank Secrecy Act.


 


8.
Fees and Expenses. The Escrow Agent shall be entitled to the Escrow Agent Fees set forth on the Information Sheet, payable
as and when stated therein. In addition, the Issuer agrees to reimburse the Escrow Agent for any reasonable expenses incurred
in connection with this Agreement, including, but not limited to,


reasonable
counsel fees. Upon receipt of the Minimum Dollar Amount, the Escrow Agent shall have a lien upon the Fund to the extent of its
fees for services as Escrow Agent.


 


9.
Indemnification and Contribution.


 


9.1
The Issuer (the "Indemnitor") agrees to indemnify the Escrow Agent and its officers, directors, employees, agents
and shareholders (collectively referred to as the " Indemnitees") against, and hold them harmless of and from, any and
all loss, liability, cost, damage and expense, including without limitation, reasonable counsel fees, which the Indemnitees may
suffer or incur by reason of any action, claim or proceeding brought against the Indemnitees arising out of or relating in any
way to this Agreement or any transaction to which this Agreement relates, unless such action, claim or proceeding is the result
of the willful misconduct or gross negligence of the Indemnitees.


 


9.2
If the indemnification provided for in Section 9.1 is applicable, but for any reason is held to be unavailable, the Indemnitor
shall contribute such amounts as are just and equitable to pay, or to reimburse the Indemnitees for, the aggregate of any and
all losses, liabilities, costs, damages and expenses, including counsel fees, actually incurred by the Indemnitees as a result
of or in connection with, and any amount paid in settlement of, any action, claim or proceeding arising out of or relating in
any way to any actions or omissions of the Indemnitor.


 


9.3
The provisions of this Article 9 shall survive any termination of this Agreement, whether by disbursement of the Fund, resignation
of the Escrow Agent or otherwise.


 


10.
Governing Law and Assignment. This Agreement shall be construed in accordance with and governed by the laws of the
State of New York and shall be binding upon the parties hereto and their respective successors and assigns; provided,
however, that any assignment or transfer by any party of its rights under this Agreement or with respect to the Escrow
Amounts or the Fund shall be void as against the Escrow Agent unless (a) written notice thereof shall be given to the Escrow Agent;
and (b) the Escrow Agent shall have consented in writing to such assignment or transfer.


 






    	 



    	 



    

 


Page
5


 


11.
Notices. All notices required to be given in connection with this Agreement shall be sent by registered or certified mail,
return receipt requested, or by hand delivery with receipt acknowledged, or by the Express Mail service offered by the United
States Post Office, and addressed, if to the Issuer or the Placement Agent, at their respective addresses set forth on the Information
Sheet, and if to the Escrow Agent, at its address set forth above, to the attention of the Trust Department.


 


12.
Severability. If any provision of this Agreement or the application thereof to any person or circumstance shall be determined
to be invalid or unenforceable, the remaining provisions of this Agreement or the application of such provision to persons or
circumstances other than those to which it is held invalid or unenforceable shall not be affected thereby and shall be valid and
enforceable to the fullest extent permitted by law.


 


13.
Execution in Several Counterparts. This Agreement may be executed in several counterparts or by separate instruments, and
all of such counterparts and instruments shall constitute one agreement, binding on all of the parties hereto.


 


14.
Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject
matter hereof and supersedes all prior agreements and understandings (written or oral) of the parties in connection therewith.


  


 


 


IN
WITNESS WHEREOF, the undersigned have executed this Agreement as of the day and year first above written.


 





	DELMAR
PHARMACEUTICALS, INC. 	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY 
	 	 	 
	 	 	 
	By:	 	By:
	Name:	 	Name:
	Title:
	 	Title:
	 
	 	 



 


 



	 	 	 
	 	 	 
	


By:

	 	 
	Name:	 	 
	Title:	 	 






 


 






    	 



    	 



    

 


 


EXHIBIT
A


 


ESCROW
AGREEMENT INFORMATION SHEET


 


1.The
Issuer


Name:
DelMar Pharmaceuticals, Inc.


Address:
999 West Broadway, Suite 720


Vancouver,
British Columbia


Canada
V5Z 1K5 


Tax
Identification Number: 99-0360497


 


2.      The
Placement Agent


Name:
Maxim Group LLC


Address:
405 Lexington Avenue

New York, NY 10174


 


3.The
Securities


Description
of the Securities to be offered: Description of the Securities to be offered: A minimum of 7,450,454 shares of DelMar Pharmaceuticals,
Inc.’s common stock together with 7,450,454 warrants to purchase one share of DelMar Pharmaceuticals, Inc.’s common
stock for gross proceeds of $5,000,000(minimum offering amount)


 


4.Minimum
Amounts and Conditions Required for Disbursement of the Escrow Account


Aggregate
dollar amount which must be collected before the Escrow Account may be disbursed to the Issuer: $5,000,000


 


5. Plan
of Distribution of the Securities


Initial
Offering Period: Through Through July 31, 2015


Extension
Period, if any: None


 


6.Title
of Escrow Account


CST&T
AAF DelMar Pharmaceuticals, Inc.


 


7.Escrow
Agent Fees and Charges


$3,500:
$1,250.00 payable at signing of the Escrow Agreement, plus $2,250.00 prior to the Closing. (Note: $250.00 online "view only"
access to the bannk account is included). A fee of $500 will be payable for document review services related to each amendment
to the Escrow Agreement. In addition, the Escrow Agent shall be paid a fee of $500.00 for each additional closing. Should the
Escrow Agent continue for more than one year, the Escrow Agent shall receive a fee of $600.00 per month, or any portion thereof,
payable in advance or the first business day of the month.


 


Distribution
charges:


$10.00
per check


$50.00
per wire


$100.00
per check returned (NSF) check


$100.00
lost check replacement fee